Cowen to host conference call to discuss first quarter 2021 financial results on Thursday, April 29. Click here for more information.

$3.9 Billion

Tilray

Sell-side

Financial Advisor, December 2020

Combination with Aphria Inc. (Pending)

Tilray is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 15 countries spanning five continents.

Aphria Inc. is a leading global cannabis company inspiring and empowering the worldwide community to live their very best life. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria Inc. has been setting the standard for the low-cost production of high-quality cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, Aphria Inc. is committed to bringing breakthrough innovation to the global cannabis market. The Company's portfolio of brands is grounded in expertly researched consumer insights designed to meet the needs of every consumer segment. Rooted in our founders' multi-generational expertise in commercial agriculture, Aphria Inc. drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships, and global expansion.

More Like This

Oct 2020

Sale to Kohlberg & Company

Financial Advisor

View Details
Sep 2020
$21 Billion

Sale to Gilead Sciences

Financial Advisor

View Details
Sep 2020

Sale to NORD Holding Unternehmensbeteiligungsgesellschaft mbH

Financial Advisor

View Details